Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $9.62 million. The enterprise value is -$2.25 million.
| Market Cap | 9.62M |
| Enterprise Value | -2.25M |
Important Dates
The next confirmed earnings date is Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QNRX has 2.01 million shares outstanding. The number of shares has increased by 518.76% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.01M |
| Shares Change (YoY) | +518.76% |
| Shares Change (QoQ) | +13.50% |
| Owned by Insiders (%) | 2.63% |
| Owned by Institutions (%) | 47.10% |
| Float | 1.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.87 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -231.18% and return on invested capital (ROIC) is -111.12%.
| Return on Equity (ROE) | -231.18% |
| Return on Assets (ROA) | -76.20% |
| Return on Invested Capital (ROIC) | -111.12% |
| Return on Capital Employed (ROCE) | -168.79% |
| Weighted Average Cost of Capital (WACC) | 10.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.83M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.01% in the last 52 weeks. The beta is 1.66, so QNRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -35.01% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 8.58 |
| Relative Strength Index (RSI) | 60.63 |
| Average Volume (20 Days) | 14,354 |
Short Selling Information
The latest short interest is 156,280, so 7.81% of the outstanding shares have been sold short.
| Short Interest | 156,280 |
| Short Previous Month | 261,876 |
| Short % of Shares Out | 7.81% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.46M |
| Pretax Income | -16.99M |
| Net Income | -16.99M |
| EBITDA | -17.36M |
| EBIT | -17.46M |
| Earnings Per Share (EPS) | -$10.43 |
Balance Sheet
The company has $14.04 million in cash and $2.17 million in debt, with a net cash position of $11.87 million or $5.91 per share.
| Cash & Cash Equivalents | 14.04M |
| Total Debt | 2.17M |
| Net Cash | 11.87M |
| Net Cash Per Share | $5.91 |
| Equity (Book Value) | 8.77M |
| Book Value Per Share | 4.47 |
| Working Capital | 9.99M |
Cash Flow
| Operating Cash Flow | -15.82M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 100,000 |
| Net Borrowing | -600,000 |
| Free Cash Flow | -10.78M |
| FCF Per Share | -$5.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -518.76% |
| Shareholder Yield | -518.76% |
| Earnings Yield | -176.61% |
| FCF Yield | -112.06% |
Analyst Forecast
The average price target for QNRX is $21.40, which is 346.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.40 |
| Price Target Difference | 346.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:35.
| Last Split Date | Apr 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |